Mid-regional proadrenomedullin (MR-proADM), C-reactive protein (CRP) and other biomarkers in the early identification of disease progression in patients with COVID-19 in the acute NHS setting.
第一作者:
Nathan,Moore
第一单位:
Microbiology Department, Basingstoke and North Hampshire Hospital, Basingstoke, UK nathan.moore@hhft.nhs.uk.
作者:
医学主题词
人类(Humans);肾上腺髓质素(Adrenomedullin);C反应蛋白质(C-Reactive Protein);疾病恶化(Disease Progression);预后(Prognosis)
DOI
10.1136/jclinpath-2021-207750
PMID
34996755
发布时间
2023-08-29
- 浏览0
Journal of clinical pathology
400-406页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



